Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — December 2019

Biotek-snakken — December 2019

Planlagt Fastgjort Låst Flyttet Biotek-snakken
149 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • N Offline
    N Offline
    Nadia6111
    wrote on sidst redigeret af
    #106

    STOCKHOLM (Nyhetsbyrån Direkt) RBC Capital Markets sänker rekommendationen för Hansa Biopharma till sector perform från top pick. Riktkursen sänks från 300 till 110 kronor.

    Det framgår av Bloomberg.

    1 Reply Last reply
    0
    • 3 Offline
      3 Offline
      3kroner
      wrote on sidst redigeret af
      #107

      Photocure (PHO) : Studieresultat er netop offentliggjort https://www.marketscreener.com/PHOTOCURE-ASA-1413243/news/Photocure-Reduced-recurrence-after-flexible-Blue-Light-Cystoscopy-with-Hexvix-in-surveillance-Ne-29748393/

      1 Reply Last reply
      0
      • P Offline
        P Offline
        peter12
        wrote on sidst redigeret af
        #108

        SGEN får godkendt EV https://seekingalpha.com/news/3527294-fda-oks-seattle-genetics-adc-for-urothelial-cancer-shares-up-6-after-hours

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #109

          Hansa Biopharma: https://www.proinvestor.com/debat/80265

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #110

            U.S. Food and Drug Administration granted accelerated approval to Padcev (enfortumab vedotin-ejfv), a Nectin-4-directed antibody and microtubule inhibitor conjugate, meaning the drug specifically targets cancer cells – in this case, the cell adhesion molecule Nectin-4, which is highly expressed in urothelial cancers. https://www.fda.gov/news-events/press-announcements/fda-approves-new-type-therapy-treat-advanced-urothelial-cancer

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #111

              Alligator: https://www.proinvestor.com/index.php?p=debat_1&postid=80274

              1 Reply Last reply
              0
              • N Offline
                N Offline
                Nadia6111
                wrote on sidst redigeret af
                #112

                Er der kommer nyt omkring Lipidor nu oppe med over 9% ?

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #113

                  DS8201 KOL views - tegner godt for ZW49, hvis den kan performe i klinikken som præklinikken viser:

                  1 Reply Last reply
                  0
                  • S Offline
                    S Offline
                    Sukkeralf
                    wrote on sidst redigeret af
                    #114

                    https://www.firstwordpharma.com/node/1689269?tsid=1

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #115

                      Interstitial lung disease is a very important side effect to monitor and be vigilant for, but KOL is concerned that practitioners are going to be hyper-vigilant and patients will be taken off a drug that's very active because of an inflated perception of interstitial lung disease

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #116

                        "There's absolutely no comparison. You wouldn't see a response rate this high in the third- or fourth-line setting. Once you get past first- and second-line therapy, you're seeing response rates in the 20% to 30% range at best. The response rate for trastuzumab deruxtecan was so high [61%] with progression-free survival for so long [16.4 months], that it knocks all other therapies out of the park."

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #117

                          Der er bekymringer omkring bivirkningsprofilen (bl.a. ILD) og det er jo her at ZW49 virkelig gerne skulle vise sit værd, da det jo bevidst er dette Zymeworks er gået efter. Så lad os håbe på at ZW49 har effekt som DS8201 og en langt bedre bivirkningsprofil, så bliver det rigtig sjovt 🙂

                          1 Reply Last reply
                          0
                          • L Offline
                            L Offline
                            lassevedel96
                            wrote on sidst redigeret af
                            #118

                            Sukkeralf, ved du hvad det er for et antistof Zyme
                            har i Phase I sammen med Eli Lilly? (jf. skemaet i deres corporate presentation)

                            1 Reply Last reply
                            0
                            • J Offline
                              J Offline
                              jvw
                              wrote on sidst redigeret af
                              #119

                              Ang Alligator Bioscience: Det er fint med et link men hvor bliver køberne af? Johnson og Johnson har reduceret deres beholding betydeligt og der er tilsyneladende udskiftning i ledelsen . Vi er nu brudt under alltime low og der er ingen støtte at finde...

                              1 Reply Last reply
                              0
                              • L Offline
                                L Offline
                                lahn1
                                wrote on sidst redigeret af
                                #120

                                Sukkeralf - kan ikke læse artiklen, men interessant i forlængelse at vores snak forleden. Er du inde i BGBIO for long eller trader du stadigvæk?

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #121

                                  https://www.firstwordpharma.com/node/1689353?tsid=1

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Sukkeralf
                                    wrote on sidst redigeret af
                                    #122

                                    DS8201 godkendt på rekord tid - må være blandt de hurtigste godkendelser ever

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Sukkeralf
                                      wrote on sidst redigeret af
                                      #123

                                      Lahn - ingen bergenbio her, men den har set rimelig stærk ud

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #124

                                        Lassevedel det ved jeg ikke - fandt på et tidspunkt ud af hvilken de havde skrottet, men kan ikke huske det pt

                                        1 Reply Last reply
                                        0
                                        • Farfar1952F Offline
                                          Farfar1952F Offline
                                          Farfar1952
                                          wrote on sidst redigeret af
                                          #125

                                          Nogen der kender forty Seven Inc. Købte lidt forleden.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper